Pot shots.
D017088:AIDS-Related Opportunistic Infections / Q000628:therapy*; D000111:Acetylcysteine / Q000627:therapeutic use*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D002417:Cattle; D002681:China / Q000453:epidemiology; D017291:Clarithromycin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D002991:Clofazimine / Q000009:adverse effects* / Q000627:therapeutic use; D003457:Cryptosporidiosis / Q000188:drug therapy*; D004338:Drug Combinations; D004977:Ethambutol / Q000627:therapeutic use; D005100:Expectorants / Q000627:therapeutic use*; D005978:Glutathione / Q000096:biosynthesis*; D006509:Hepatitis B / Q000453:epidemiology / Q000628:therapy*; D006801:Humans; D007136:Immunoglobulins / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D007558:Italy; D007917:Leprostatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy*; D010679:Philippines; D011480:Protease Inhibitors / Q000009:adverse effects*; D015996:Survival Rate; D013624:Taiwan; D013947:Thymosin / Q000627:therapeutic use*; D015215:Zidovudine / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D000998:Antiviral Agents; D004338:Drug Combinations; D005100:Expectorants; D007136:Immunoglobulins; D016898:Interferon-alpha; D007917:Leprostatic Agents; D011480:Protease Inhibitors; D015215:Zidovudine; D013947:Thymosin; D004977:Ethambutol; D002991:Clofazimine; D005978:Glutathione; D017291:Clarithromycin; D000111:Acetylcysteine